Semarion

Semarion is built on fostering collaboration across disciplines to tackle foundational bottlenecks in drug discovery. We operate at the edge of the physical and life sciences by using microchip industry materials and techniques to transform cell-based research.

Semarion is a spin-out from Cambridge University with a mission to accelerate the pace of drug discovery. We are revolutionising adherent cell screening to produce better data, faster. Our proprietary SemaCyte® cell microcarrier platform leverages novel materials physics to deliver assay flexibility, miniaturisation, and multiplexing with existing tools and workflows. Our microcarriers function as ultra-miniaturized, magnetically steerable wells which can carrier small colonies of cells to enable more powerful assaying workflows and new experimental paradigms.